射频消融联合胆道支架置入与单纯支架置入治疗恶性胆道狭窄的系统评价与Meta分析
本文系统检索并Meta分析了比较射频消融(RFA)联合胆道支架置入与单纯支架置入治疗不可切除恶性胆道狭窄的研究,共纳入9项研究505例患者。结果显示RFA组支架通畅时间加权均数差为50.6天(95%CI 32.83-68.48),生存分析风险比为1.395(95%CI 1.145-1.7,P<.001),但RFA组术后腹痛风险较高(31% vs 20%,P=.003),胆管炎、急性胆囊炎、胰腺炎和胆道出血风险无显著差异。
要点
- RFA联合支架置入较单纯支架置入的支架通畅时间加权均数差为50.6天(95%CI 32.83-68.48),利于RFA组。
- 重建Kaplan-Meier数据的生存分析显示RFA组生存改善,风险比为1.395(95%CI 1.145-1.7,P<.001)。
- RFA组术后腹痛风险高于单纯支架组(31% vs 20%,P=.003),其余不良事件风险无显著差异。
核心结论
- 基于观察性研究的有限数据,RFA在恶性胆道狭窄患者中被发现是安全的,并与支架通畅时间改善相关;此外,RFA可能与该类患者生存改善相关。
研究设计与样本
- 系统评价与Meta分析,全面检索电子数据库,纳入比较RFA联合胆道支架置入与单纯支架置入的研究,共9项研究(包括2篇摘要)505例患者。
- 支架通畅时间数据采用逆方差法合并入随机效应模型,生存分析采用Cox回归分析计算风险比,并使用GRADE框架解读 findings。
主要发现
- 支架通畅时间的合并加权均数差为50.6天(95%CI 32.83-68.48),利于接受RFA的患者。
- 重建Kaplan-Meier数据的合并生存分析显示RFA组生存改善,风险比为1.395(95%CI 1.145-1.7,P<.001)。
- RFA组术后腹痛风险高于单纯支架组(31% vs 20%,P=.003)。
- RFA组与单纯支架组在胆管炎、急性胆囊炎、胰腺炎和胆道出血风险方面无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出该分析基于观察性研究的有限数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Unresectable malignant biliary strictures are generally managed by palliative stent placement for drainage of biliary tree. Recently, radiofrequency ablation (RFA) has been used to improve the patency of biliary stents in these patients. Several studies have evaluated the effectiveness of biliary stent placement with RFA on stent patency and patient survival with variable results. We performed this meta-analysis to evaluate the efficacy and safety of biliary stent placement with RFA compared with stent placement alone in patients with malignant biliary strictures. METHODS: We performed a comprehensive search of electronic databases for all studies comparing RFA with biliary stent placement versus stent placement only. Measured outcomes included patient survival, stent patency, and procedure-related adverse events. An inverse variance method was used to pool data on stent patency into a random-effects model. Cox-regression analysis was used to calculate hazard ratio for survival analysis. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework to interpret our findings. RESULTS: Nine studies (including 2 abstracts) with a total of 505 patients were included in the meta-analysis. The pooled weighted mean difference in stent patency was 50.6 days (95% confidence interval [CI], 32.83-68.48), favoring patients receiving RFA. Pooled survival analysis of the reconstructed Kaplan-Meier data showed improved survival in patients treated with RFA (hazard ratio, 1.395; 95% CI, 1.145-1.7; P < .001). However, RFA was associated with a higher risk of postprocedural abdominal pain (31% vs 20%, P = .003). Our analysis did not show significant difference between the RFA and stent placement-only groups with regard to the risk of cholangitis, acute cholecystitis, pancreatitis, and hemobilia. CONCLUSIONS: In the light of this limited data based on observational studies, RFA was found to be safe and was associated with improved stent patency in patients with malignant biliary strictures. In addition, RFA may be associated with improved survival in these patients.
引用
- Sofi AA, Khan MA, Das A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2017. PMID: 29108980. doi:10.1016/j.gie.2017.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。